SCHEMBL8334146

SCHEMBL8334146

CCN=C(Nc1cccc2c1CCC2)N(CC)c1cccc(CC)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.43
L3MBTL1 Q9Y468 2/20 0.43
MEN1 O00255 4/20 0.41
KMT2A Q03164 4/20 0.41
ALDH1A1 P00352 3/20 0.41
THRA P10827 1/20 0.41
THRB P10828 1/20 0.41
SIGMAR1 Q99720 3/20 0.39
TSHR P16473 2/20 0.38
GRIN2D O15399 1/20 0.37
GRIN3B O60391 1/20 0.37
GRIN1 Q05586 1/20 0.37
GRIN2A Q12879 1/20 0.37
GRIN2B Q13224 1/20 0.37
GRIN2C Q14957 1/20 0.37
GRIN3A Q8TCU5 1/20 0.37
RXRA P19793 1/20 0.35
RXRB P28702 1/20 0.35
RXRG P48443 1/20 0.35
KDM4E B2RXH2 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6724962 0.84 LMNA (0.45) LMNAL3MBTL1MEN1KMT2AALDH1A1
SCHEMBL8329446 0.78 LMNA (0.41) LMNAL3MBTL1MEN1KMT2AALDH1A1
SCHEMBL9438416 0.77 SIGMAR1 (0.45) MEN1KMT2AALDH1A1THRBSIGMAR1
SCHEMBL8334142 0.77 SIGMAR1 (0.43) LMNAMEN1KMT2ASIGMAR1TSHR
SCHEMBL6717069 0.76 LMNA (0.46) LMNAL3MBTL1MEN1KMT2AALDH1A1
SCHEMBL7460721 0.76 LMNA (0.39) LMNAL3MBTL1MEN1KMT2AALDH1A1
SCHEMBL6717417 0.74 LMNA (0.43) LMNAL3MBTL1MEN1KMT2AALDH1A1
SCHEMBL6724971 0.73 SIGMAR1 (0.62) LMNAMEN1KMT2ASIGMAR1TSHR
SCHEMBL6717249 0.73 SIGMAR1 (0.51) LMNAL3MBTL1SIGMAR1TSHRRXRA
SCHEMBL9438320 0.71 SIGMAR1 (0.62) LMNAL3MBTL1MEN1KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0918460-A1 METHODS OF TREATMENT OF EYE TRAUMA AND DISORDERS CAMBRIDGE NEUROSCIENCE, INC. (US) 1999-06-02 EP disclosed
WO-1999002145-A1 COMBINATION DRUG THERAPIES COMPRISING AMINOGLYCOSIDE ANTIBIOTICS AND N,N'-DISUBSTITUTED GUANIDINES CAMBRIDGE NEUROSCIENCE, INC. (US) 1999-01-21 WO disclosed
WO-1998004131-A1 METHODS OF TREATMENT OF EYE TRAUMA AND DISORDERS CAMBRIDGE NEUROSCIENCE, INC. (US) 1998-02-05 WO disclosed